Header cover image

Malaysian (KLSE) Clinical Research and Equipment Industry Analysis

UpdatedNov 24, 2024
DataAggregated Company Financials
Companies1
  • 7D0%
  • 3M-13.2%
  • 1Y-29.0%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.5%, driven by pullbacks from every company within the industry. Overall the industry is down 31% in 12 months.

Industry Valuation and Performance

Has the Malaysian Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 24 Nov 2024RM 45.3mRM 9.7m-RM 7,896,906.00n/a-5.7x4.6x
Tue, 22 Oct 2024RM 46.7mRM 9.7m-RM 7,896,906.00n/a-5.9x4.8x
Thu, 19 Sep 2024RM 50.1mRM 9.7m-RM 7,896,906.00n/a-6.3x5.1x
Sat, 17 Aug 2024RM 51.5mRM 10.7m-RM 17,594,906.00n/a-2.9x4.8x
Mon, 15 Jul 2024RM 54.9mRM 10.7m-RM 17,594,906.00n/a-3.1x5.1x
Wed, 12 Jun 2024RM 57.6mRM 9.6m-RM 19,048,906.00n/a-3x6x
Fri, 10 May 2024RM 56.3mRM 9.6m-RM 19,048,906.00n/a-3x5.9x
Sun, 07 Apr 2024RM 57.6mRM 9.6m-RM 19,048,906.00n/a-3x6x
Tue, 05 Mar 2024RM 61.7mRM 9.6m-RM 19,296,000.00n/a-3.2x6.4x
Thu, 01 Feb 2024RM 61.7mRM 8.4m-RM 14,246,000.00n/a-4.3x7.4x
Sat, 30 Dec 2023RM 61.1mRM 8.4m-RM 14,246,000.00n/a-4.3x7.3x
Mon, 27 Nov 2023RM 63.8mRM 8.4m-RM 14,246,000.00n/a-4.5x7.6x
Wed, 25 Oct 2023RM 68.6mRM 8.4m-RM 14,246,000.00n/a-4.8x8.2x
Fri, 22 Sep 2023RM 68.6mRM 8.4m-RM 14,246,000.00n/a-4.8x8.2x
Sun, 20 Aug 2023RM 60.4mRM 12.5mRM 781.0k77.3x77.3x4.8x
Tue, 18 Jul 2023RM 59.2mRM 12.5mRM 781.0k75.9x75.9x4.8x
Thu, 15 Jun 2023RM 59.9mRM 12.5mRM 781.0k76.7x76.7x4.8x
Sat, 13 May 2023RM 79.4mRM 16.9mRM 5.6m14.2x14.2x4.7x
Mon, 10 Apr 2023RM 74.9mRM 16.9mRM 5.6m13.4x13.4x4.4x
Wed, 08 Mar 2023RM 85.9mRM 16.9mRM 5.6m15.1x15.3x5.1x
Fri, 03 Feb 2023RM 97.0mRM 22.9mRM 7.8m12.4x12.4x4.2x
Sun, 01 Jan 2023RM 99.6mRM 22.9mRM 7.8m12.7x12.7x4.4x
Tue, 29 Nov 2022RM 93.2mRM 22.9mRM 7.8m11.9x11.9x4.1x
Thu, 27 Oct 2022RM 83.2mRM 28.4mRM 7.2m11.5x11.5x2.9x
Sat, 24 Sep 2022RM 91.9mRM 28.4mRM 7.2m12.7x12.7x3.2x
Mon, 22 Aug 2022RM 87.6mRM 22.0mRM 1.1m79x79x4x
Wed, 20 Jul 2022RM 132.9mRM 22.0mRM 1.1m120x119.9x6.1x
Fri, 17 Jun 2022RM 88.8mRM 22.0mRM 1.1m80.2x80.1x4x
Sun, 15 May 2022RM 88.8mRM 18.5m-RM 655,882.00n/a-135.4x4.8x
Tue, 12 Apr 2022RM 99.4mRM 18.5m-RM 655,882.00n/a-151.5x5.4x
Thu, 10 Mar 2022RM 91.9mRM 18.5m-RM 655,882.00n/a-140.1x5x
Sat, 05 Feb 2022RM 139.1mRM 11.0m-RM 3,220,882.00n/a-43.2x12.6x
Mon, 03 Jan 2022RM 144.1mRM 11.0m-RM 3,220,882.00n/a-44.7x13.1x
Wed, 01 Dec 2021RM 319.2mRM 1.8m-RM 4,292,882.00n/a-74.4x179x
Price to Earnings Ratio

-74.4x


Total Market Cap: RM 319.2mTotal Earnings: -RM 4,292,882.00Total Revenue: RM 1.8mTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Clinical Research and Equipment Industry Price to Earnings3Y Average -0.9x202220232024
Current Industry PE
    There is only one company in the Malaysian Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 76% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Malaysian Clinical Research and Equipment compare with similar industries?

MY Market0.092%
Healthcare0.90%
Life Sciences0%
Clinical Research and Equipment0%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News